Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

The influence of cognition, anxiety and psychiatric disorders over treatment adherence in uncontrolled hypertensive patients.

Jacobs Ú, De Castro MS, Fuchs FD, Ferreira MB.

PLoS One. 2011;6(8):e22925. doi: 10.1371/journal.pone.0022925. Epub 2011 Aug 9.

2.

The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial.

Lithell H, Hansson L, Skoog I, Elmfeldt D, Hofman A, Olofsson B, Trenkwalder P, Zanchetti A; SCOPE Study Group.

J Hypertens. 2003 May;21(5):875-86.

PMID:
12714861
3.

Comparison of losartan and hydrochlorothiazide on cognitive function and quality of life in hypertensive patients.

Tedesco MA, Ratti G, Mennella S, Manzo G, Grieco M, Rainone AC, Iarussi D, Iacono A.

Am J Hypertens. 1999 Nov;12(11 Pt 1):1130-4.

PMID:
10604491
4.

Relationship between antihypertensive drug therapy and cognitive function in elderly hypertensive patients with memory complaints.

Hanon O, Pequignot R, Seux ML, Lenoir H, Bune A, Rigaud AS, Forette F, Girerd X.

J Hypertens. 2006 Oct;24(10):2101-7.

PMID:
16957572
5.

Differences in adherence to antihypertensive medication regimens according to psychiatric diagnosis: results of a Korean population-based study.

Kim HK, Park JH, Park JH, Kim JH.

Psychosom Med. 2010 Jan;72(1):80-7. doi: 10.1097/PSY.0b013e3181c4e3e9. Epub 2009 Nov 20.

PMID:
19933508
6.

Effect of a 36-month pharmaceutical care program on pharmacotherapy adherence in elderly diabetic and hypertensive patients.

Obreli-Neto PR, Guidoni CM, de Oliveira Baldoni A, Pilger D, Cruciol-Souza JM, Gaeti-Franco WP, Cuman RK.

Int J Clin Pharm. 2011 Aug;33(4):642-9. doi: 10.1007/s11096-011-9518-x. Epub 2011 May 5.

PMID:
21544559
7.
8.

Barriers to adherence and hypertension control in a racially diverse representative sample of elderly primary care patients.

Turner BJ, Hollenbeak C, Weiner MG, Ten Have T, Roberts C.

Pharmacoepidemiol Drug Saf. 2009 Aug;18(8):672-81. doi: 10.1002/pds.1766.

PMID:
19479901
9.

The effect of psychiatric comorbidity on hypertensive patients' perception of medication side-effects.

Guha P, Ghosal M, Chowdhury SP, Chakravarty D.

J Indian Med Assoc. 2010 Sep;108(9):576-8, 580, 582.

PMID:
21510530
10.

Impact of supportive measures on drug adherence in patients with essential hypertension treated with valsartan: the randomized, open-label, parallel group study VALIDATE.

Düsing R, Handrock R, Klebs S, Tousset E, Vrijens B.

J Hypertens. 2009 Apr;27(4):894-901. doi: 10.1097/HJH.0b013e328323f9be.

PMID:
19300114
11.

Effects of six anti-hypertensive medications on cognitive performance.

Muldoon MF, Waldstein SR, Ryan CM, Jennings JR, Polefrone JM, Shapiro AP, Manuck SB.

J Hypertens. 2002 Aug;20(8):1643-52.

PMID:
12172327
12.

Association between depressive and anxiety disorders and adherence to antihypertensive medication in community-living elderly adults.

Gentil L, Vasiliadis HM, Préville M, Bossé C, Berbiche D.

J Am Geriatr Soc. 2012 Dec;60(12):2297-301. doi: 10.1111/j.1532-5415.2012.04239.x. Epub 2012 Oct 30.

PMID:
23110563
13.

[Relationships between insight and medication adherence in subjects with psychosis].

Droulout T, Liraud F, Verdoux H.

Encephale. 2003 Sep-Oct;29(5):430-7. French.

PMID:
14615692
14.

Exploring the impact of depressive symptoms and medication beliefs on medication adherence in hypertension--a primary care study.

Maguire LK, Hughes CM, McElnay JC.

Patient Educ Couns. 2008 Nov;73(2):371-6. doi: 10.1016/j.pec.2008.06.016.

PMID:
18692978
15.

Does a combination pill of antihypertensive drugs improve medication adherence in Japanese? A randomized controlled trial.

Matsumura K, Arima H, Tominaga M, Ohtsubo T, Sasaguri T, Fujii K, Fukuhara M, Uezono K, Morinaga Y, Ohta Y, Otonari T, Kawasaki J, Kato I, Tsuchihashi T; COMFORT Investigators.

Circ J. 2012;76(6):1415-22. Epub 2012 Mar 15.

16.

[Influence of psychosocial factors on adherence to antihypertensive drug therapy: results from a Cardiovascular Health Program cohort followed in the Metropolitan Region of Santiago, Chile].

Sandoval D, Chacón J, Muñoz R, Henríquez Ó, Koch E, Romero T.

Rev Med Chil. 2014 Oct;142(10):1245-52. doi: 10.4067/S0034-98872014001000003. Spanish.

17.

Alcohol screening scores and medication nonadherence.

Bryson CL, Au DH, Sun H, Williams EC, Kivlahan DR, Bradley KA.

Ann Intern Med. 2008 Dec 2;149(11):795-804.

PMID:
19047026
18.

Effect of telmisartan/hydrochlorothiazide vs lisinopril/hydrochlorothiazide combination on ambulatory blood pressure and cognitive function in elderly hypertensive patients.

Fogari R, Mugellini A, Zoppi A, Lazzari P, Destro M, Rinaldi A, Preti P.

J Hum Hypertens. 2006 Mar;20(3):177-85.

PMID:
16306998
19.

The effect of the content of the knowledge on adherence to medication in hypertensive patients.

Karaeren H, Yokuşoğlu M, Uzun S, Baysan O, Köz C, Kara B, Kirilmaz A, Naharci I, Pinar M, Yilmaz MB, Uzun M.

Anadolu Kardiyol Derg. 2009 Jun;9(3):183-8.

20.

Effects of hypertension therapy based on eprosartan on systolic arterial blood pressure and cognitive function: primary results of the Observational Study on Cognitive function And Systolic Blood Pressure Reduction open-label study.

Hanon O, Berrou JP, Negre-Pages L, Goch JH, Nádházi Z, Petrella R, Sedefdjian A, Sévenier F, Shlyakhto EV, Pathak A.

J Hypertens. 2008 Aug;26(8):1642-50. doi: 10.1097/HJH.0b013e328301a280.

PMID:
18622244

Supplemental Content

Support Center